MRI pioneer Van Horssen leaves Mobile Technology

Article

One of the earliest and most successful innovators in the mobilediagnostic imaging industry is bowing out, at least temporarily.Ronald D. Van Horssen will leave his position next month as presidentand CEO of Mobile Technology Inc. of Los Angeles, the

One of the earliest and most successful innovators in the mobilediagnostic imaging industry is bowing out, at least temporarily.Ronald D. Van Horssen will leave his position next month as presidentand CEO of Mobile Technology Inc. of Los Angeles, the mobile imagingcompany he organized in 1983.

The 41-year-old Van Horssen cited personal reasons for hisdeparture.

"It's just an evolution; the natural course of things,"he said.

MTI became the world's largest mobile MRI provider throughits acquisition four years ago of Mediq's mobile CT and MRI fleet(SCAN 4/13/88). Mediq had been the previous mobile leader.

The privately held company expanded its mobile MRI base to100 systems by buying Linc Scientific Imaging a year and a halfago (SCAN 12/12/90). MTI currently boasts a fleet of 101 MRI systems,20 CT systems and seven lithotripsy units. Annual revenues totalabout $120 million.

Van Horssen's successor is Joseph W. Cilurzo, former presidentof Jobst, a Toledo manufacturer of vascular pumps and health-relatedequipment. His appointment to MTI's top spot will give Cilurzohis first exposure to the mobile imaging industry.

Brentwood Associates, a Los Angeles-based investment company,purchased a majority interest in MTI in 1990.

Van Horssen got his start in imaging services just as MRI emergedas a clinically viable diagnostic modality. His discussions withJohnson & Johnson in the early 1980s led to the introductionof one of the first superconducting systems designed for mobileuse.

Van Horssen plans a sabbatical at his vacation home at JacksonHole, WY. "I'm taking some personal time, then will planwhat to do for the next 10 years," he told SCAN.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.